Teneligliptin-associated bullous pemphigoid in an elderly man with diabetes

Guliani Ankur; Bishnoi Anuradha; Aggarwal Divya; Parsad Davinder

首页> 外文期刊>Postgraduate Medical Journal >Teneligliptin-associated bullous pemphigoid in an elderly man with diabetes

【24h】

Teneligliptin-associated bullous pemphigoid in an elderly man with diabetes

机译：Teneligliptin相关的大疱在一位糖尿病的年长人中的大疱性大疱

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Postgraduate Medical Journal》 |2018年第1117期|共2页
作者
Guliani Ankur; Bishnoi Anuradha; Aggarwal Divya; Parsad Davinder;
展开▼
作者单位

Postgrad Inst Med Educ &

Res Dept Dermatol Venereol &

Leprol Chandigarh 160012 India;

Postgrad Inst Med Educ &

Res Dept Dermatol Venereol &

Leprol Chandigarh 160012 India;

Postgrad Inst Med Educ &

Res Dept Histopathol Chandigarh India;

Postgrad Inst Med Educ &

Res Dept Dermatol Venereol &

Leprol Chandigarh 160012 India;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Teneligliptin-associated bullous pemphigoid in an elderly man with diabetes [J] . Guliani Ankur, Bishnoi Anuradha, Aggarwal Divya, Postgraduate Medical Journal . 2018,第1117期

机译：Teneligliptin相关的大疱在一位糖尿病的年长人中的大疱性大疱
2. Reply to: "Comment on 'Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study' and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pemphigoid'' [J] . Varpuluoma Outi, Tasanen Kaisa, Huilaja Laura Journal of the American Academy of Dermatology . 2019,第6期

机译：回复：“评论除了二肽基肽酶-4抑制剂以外的口腔糖尿病药物与大疱性毒性的抑制剂无关：芬兰国家病例对照研究'以及胰高血糖素肽-1受体激动剂诱导的大疱病 '
3. Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study'' and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pemphigoid [J] . Schwager Zachary, Mikailov Anar, Lipworth Adam D. Journal of the American Academy of Dermatology . 2019,第6期

机译：评论“除了二肽基肽酶-4抑制剂以外的口腔糖尿病药物与大疱性疱疹病毒（Dellous Pemphigoid）无关：芬兰国家病例对照研究”“和胰高血糖素肽-1受体激动剂诱导的大疱病毒诱导的大疱病
4. Predicting the onset of bullous pemphigoid with co-morbidities: A survey based on a nationwide medical database [C] . Chu-Cheng Kuo, Fang-Chi Yang, Meng-Han Yang, IEEE International Conference on Bioinformatics and Biomedicine . 2013

机译：预测并发大疱性天疱疮的发病率：基于全国医学数据库的一项调查
5. Structural and functional analysis of bullous pemphigoid antigen1 (BPAG1) [D] . Jefferson, Julius J. 2007

机译：大疱性类天疱疮抗原1（BPAG1）的结构和功能分析
6. Mucous Membrane Pemphigoid Bullous Pemphigoid and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature [O] . Coralie Zumelzu, Marina Alexandre, Christelle Le Roux, 2018

机译：粘液膜天疱疮大疱性天疱疮和抗程序性死亡1 /程序性死亡配体1：一名老年妇女在用Pembrolizumab治疗转移性黑色素瘤后发展成粘液膜天疱疮并进行文献复习
7. Comment on “Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study” and a case report of glucagon-like peptide-1 receptor agonist–induced bullous pemphigoid [O] . Zachary Schwager, Anar Mikailov, Adam D. Lipworth 2019

机译：评论“除了二肽基肽酶-4抑制剂以外的口腔糖尿病药物与大疱性毒性的情况无关：芬兰国家病例对照研究”和胰高血糖素肽-1受体激动剂诱导的大疱性大疱性Pemphigoid的病例报告

Teneligliptin-associated bullous pemphigoid in an elderly man with diabetes

著录项

相似文献

相关主题

期刊订阅